1. Home
  2. FAMI vs PTIX Comparison

FAMI vs PTIX Comparison

Compare FAMI & PTIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FAMI
  • PTIX
  • Stock Information
  • Founded
  • FAMI 2015
  • PTIX 1994
  • Country
  • FAMI China
  • PTIX United States
  • Employees
  • FAMI N/A
  • PTIX N/A
  • Industry
  • FAMI Packaged Foods
  • PTIX Biotechnology: Pharmaceutical Preparations
  • Sector
  • FAMI Consumer Staples
  • PTIX Health Care
  • Exchange
  • FAMI Nasdaq
  • PTIX Nasdaq
  • Market Cap
  • FAMI 3.4M
  • PTIX 3.9M
  • IPO Year
  • FAMI 2018
  • PTIX 2016
  • Fundamental
  • Price
  • FAMI $0.28
  • PTIX $0.64
  • Analyst Decision
  • FAMI
  • PTIX
  • Analyst Count
  • FAMI 0
  • PTIX 0
  • Target Price
  • FAMI N/A
  • PTIX N/A
  • AVG Volume (30 Days)
  • FAMI 544.2K
  • PTIX 239.9K
  • Earning Date
  • FAMI 11-29-2024
  • PTIX 11-14-2024
  • Dividend Yield
  • FAMI N/A
  • PTIX N/A
  • EPS Growth
  • FAMI N/A
  • PTIX N/A
  • EPS
  • FAMI 0.13
  • PTIX N/A
  • Revenue
  • FAMI $86,261,500.00
  • PTIX N/A
  • Revenue This Year
  • FAMI N/A
  • PTIX N/A
  • Revenue Next Year
  • FAMI N/A
  • PTIX N/A
  • P/E Ratio
  • FAMI $2.28
  • PTIX N/A
  • Revenue Growth
  • FAMI N/A
  • PTIX N/A
  • 52 Week Low
  • FAMI $0.17
  • PTIX $0.49
  • 52 Week High
  • FAMI $2.35
  • PTIX $1.87
  • Technical
  • Relative Strength Index (RSI)
  • FAMI 46.10
  • PTIX 50.85
  • Support Level
  • FAMI $0.28
  • PTIX $0.54
  • Resistance Level
  • FAMI $0.32
  • PTIX $0.64
  • Average True Range (ATR)
  • FAMI 0.03
  • PTIX 0.14
  • MACD
  • FAMI -0.00
  • PTIX -0.01
  • Stochastic Oscillator
  • FAMI 44.44
  • PTIX 20.97

About FAMI Farmmi Inc.

Farmmi Inc is a supplier of agricultural products. The products of the company are Shiitake Mushroom, Mu Er Mushroom and other edible fungi and other agricultural products. The majority of products are sold in mainland China.

About PTIX Protagenic Therapeutics Inc.

Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.

Share on Social Networks: